nodes	percent_of_prediction	percent_of_DWPC	metapath
Levallorphan—Naloxone—ESR1—breast cancer	0.0965	0.289	CrCbGaD
Levallorphan—Naloxone—CYP3A4—breast cancer	0.0493	0.147	CrCbGaD
Levallorphan—Naloxone—ALB—breast cancer	0.043	0.128	CrCbGaD
Levallorphan—Naloxone—ABCB1—breast cancer	0.041	0.123	CrCbGaD
Levallorphan—Dextromethorphan—CYP2D6—breast cancer	0.0407	0.122	CrCbGaD
Levallorphan—Dextromethorphan—CYP3A4—breast cancer	0.0349	0.104	CrCbGaD
Levallorphan—Dextromethorphan—ABCB1—breast cancer	0.0291	0.0869	CrCbGaD
Levallorphan—OPRM1—G alpha (i) signalling events—CXCR4—breast cancer	0.00356	0.00534	CbGpPWpGaD
Levallorphan—OPRM1—G alpha (i) signalling events—CXCL12—breast cancer	0.00356	0.00534	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—RAF1—breast cancer	0.00339	0.00509	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—RELA—breast cancer	0.00337	0.00506	CbGpPWpGaD
Levallorphan—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—breast cancer	0.00333	0.005	CbGpPWpGaD
Levallorphan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—breast cancer	0.00333	0.005	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—CCL20—breast cancer	0.0033	0.00497	CbGpPWpGaD
Levallorphan—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—breast cancer	0.0033	0.00496	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—CD4—breast cancer	0.0033	0.00496	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—GPER1—breast cancer	0.00325	0.00489	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—LPAR1—breast cancer	0.0032	0.00481	CbGpPWpGaD
Levallorphan—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRB—breast cancer	0.00319	0.00479	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—STARD8—breast cancer	0.00318	0.00478	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—NMBR—breast cancer	0.00312	0.00468	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—IL1B—breast cancer	0.00305	0.00458	CbGpPWpGaD
Levallorphan—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—breast cancer	0.00299	0.00449	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—JUN—breast cancer	0.00295	0.00444	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—GPER1—breast cancer	0.00295	0.00444	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—CNR2—breast cancer	0.00295	0.00443	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—PTGER1—breast cancer	0.0029	0.00435	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—NMBR—breast cancer	0.00283	0.00425	CbGpPWpGaD
Levallorphan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—breast cancer	0.00283	0.00425	CbGpPWpGaD
Levallorphan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—breast cancer	0.00283	0.00425	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—MAPK8—breast cancer	0.00279	0.0042	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—WNT1—breast cancer	0.00277	0.00416	CbGpPWpGaD
Levallorphan—OPRM1—IL4-mediated signaling events—PIK3CA—breast cancer	0.00271	0.00408	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—PTGER1—breast cancer	0.00263	0.00395	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—CCL27—breast cancer	0.00258	0.00388	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—PDE2A—breast cancer	0.00258	0.00388	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—CXCL3—breast cancer	0.00258	0.00388	CbGpPWpGaD
Levallorphan—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—breast cancer	0.00256	0.00384	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—AGTR2—breast cancer	0.00253	0.00381	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—CXCL2—breast cancer	0.00253	0.00381	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—PTHLH—breast cancer	0.0025	0.00376	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—MAPK3—breast cancer	0.00244	0.00367	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—EDNRB—breast cancer	0.00243	0.00364	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—WNT10B—breast cancer	0.00241	0.00362	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—TGFB1—breast cancer	0.00237	0.00356	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—PDE2A—breast cancer	0.00235	0.00352	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—CCL27—breast cancer	0.00235	0.00352	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—CXCL3—breast cancer	0.00235	0.00352	CbGpPWpGaD
Levallorphan—OPRM1—IL4-mediated signaling events—AKT1—breast cancer	0.00222	0.00333	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—CALCA—breast cancer	0.0022	0.00331	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—CXCR4—breast cancer	0.00215	0.00324	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—CXCL12—breast cancer	0.00215	0.00324	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—AGTR1—breast cancer	0.00195	0.00293	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—RGS2—breast cancer	0.00189	0.00284	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—CCL20—breast cancer	0.00187	0.00281	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—HRAS—breast cancer	0.00186	0.0028	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—LGR6—breast cancer	0.00183	0.00275	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CCDC88C—breast cancer	0.00183	0.00275	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—LPAR1—breast cancer	0.00181	0.00272	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—IL6—breast cancer	0.00178	0.00268	CbGpPWpGaD
Levallorphan—OPRM1—Peptide ligand-binding receptors—CXCL8—breast cancer	0.00175	0.00263	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—GPER1—breast cancer	0.00174	0.00262	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—SFRP1—breast cancer	0.00174	0.00262	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—RGS2—breast cancer	0.00172	0.00258	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—PDE4D—breast cancer	0.00171	0.00257	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—CCL20—breast cancer	0.0017	0.00255	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—NMBR—breast cancer	0.00167	0.00251	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—CNR2—breast cancer	0.00166	0.0025	CbGpPWpGaD
Levallorphan—OPRM1—TCR Signaling Pathway—AKT1—breast cancer	0.00165	0.00247	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—LPAR1—breast cancer	0.00164	0.00247	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—HEYL—breast cancer	0.00155	0.00234	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PTGER1—breast cancer	0.00155	0.00234	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CUL5—breast cancer	0.00155	0.00234	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—PDE4D—breast cancer	0.00155	0.00233	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—CNR2—breast cancer	0.00151	0.00227	CbGpPWpGaD
Levallorphan—OPRM1—G alpha (i) signalling events—CXCL8—breast cancer	0.00147	0.00221	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—RSPO3—breast cancer	0.00146	0.0022	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—AGTR2—breast cancer	0.00143	0.00215	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—CXCL2—breast cancer	0.00143	0.00215	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—WWOX—breast cancer	0.00142	0.00214	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—WNT10B—breast cancer	0.00142	0.00214	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—WNT1—breast cancer	0.00142	0.00214	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—PTHLH—breast cancer	0.00142	0.00213	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—INHBB—breast cancer	0.00139	0.00208	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CCL27—breast cancer	0.00139	0.00208	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PDE2A—breast cancer	0.00139	0.00208	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CXCL3—breast cancer	0.00139	0.00208	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—EDNRB—breast cancer	0.00137	0.00206	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—DLL4—breast cancer	0.00132	0.00199	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—BMPR2—breast cancer	0.00132	0.00199	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—CXCL2—breast cancer	0.0013	0.00195	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—AGTR2—breast cancer	0.0013	0.00195	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—PTHLH—breast cancer	0.00129	0.00193	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CDH5—breast cancer	0.00127	0.0019	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—CALCA—breast cancer	0.00125	0.00187	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—EDNRB—breast cancer	0.00124	0.00187	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—SFRP2—breast cancer	0.00124	0.00187	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PRLR—breast cancer	0.00122	0.00183	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—CXCR4—breast cancer	0.00122	0.00183	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—CXCL12—breast cancer	0.00122	0.00183	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—VCP—breast cancer	0.00118	0.00177	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—GLI2—breast cancer	0.00118	0.00177	CbGpPWpGaD
Levallorphan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	0.00117	0.00176	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—LEPR—breast cancer	0.00116	0.00174	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—CALCA—breast cancer	0.00113	0.0017	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—CXCL12—breast cancer	0.00111	0.00166	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—CXCR4—breast cancer	0.00111	0.00166	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—AGTR1—breast cancer	0.0011	0.00165	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—ARHGDIA—breast cancer	0.00108	0.00162	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—FST—breast cancer	0.00105	0.00158	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—HEY2—breast cancer	0.00104	0.00156	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—RPS6KB2—breast cancer	0.00102	0.00154	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—RGS2—breast cancer	0.00101	0.00152	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CCL20—breast cancer	0.001	0.00151	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—AGTR1—breast cancer	0.000999	0.0015	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—ITPR1—breast cancer	0.000988	0.00148	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—LPAR1—breast cancer	0.00097	0.00146	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—TLE3—breast cancer	0.00097	0.00146	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—HEY1—breast cancer	0.00096	0.00144	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—DLL1—breast cancer	0.000942	0.00142	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—HIST1H2BK—breast cancer	0.000925	0.00139	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—HIST1H2BC—breast cancer	0.000925	0.00139	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—GRB7—breast cancer	0.000916	0.00138	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PDE4D—breast cancer	0.000916	0.00138	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—CSF2—breast cancer	0.000912	0.00137	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—TAB2—breast cancer	0.0009	0.00135	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—ITPR1—breast cancer	0.000897	0.00135	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CNR2—breast cancer	0.000893	0.00134	CbGpPWpGaD
Levallorphan—OPRM1—GPCR ligand binding—CXCL8—breast cancer	0.000892	0.00134	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—MMP3—breast cancer	0.000891	0.00134	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—DKK1—breast cancer	0.000872	0.00131	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—VEGFC—breast cancer	0.000865	0.0013	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—JAG2—breast cancer	0.000852	0.00128	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—WNT1—breast cancer	0.00084	0.00126	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—PLA2G4A—breast cancer	0.000838	0.00126	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—CSF2—breast cancer	0.000828	0.00124	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—NOTCH4—breast cancer	0.000796	0.0012	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—GZMB—breast cancer	0.000791	0.00119	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CXCL2—breast cancer	0.000768	0.00115	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—AGTR2—breast cancer	0.000768	0.00115	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PTHLH—breast cancer	0.000759	0.00114	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—BMP2—breast cancer	0.000759	0.00114	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—EDNRB—breast cancer	0.000735	0.0011	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PGR—breast cancer	0.000728	0.00109	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—THBS1—breast cancer	0.000724	0.00109	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—FLT1—breast cancer	0.000691	0.00104	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—FGF3—breast cancer	0.000688	0.00103	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—SQSTM1—breast cancer	0.000688	0.00103	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—PIK3CG—breast cancer	0.000685	0.00103	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—JAG1—breast cancer	0.00068	0.00102	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PARP1—breast cancer	0.000677	0.00102	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—NOTCH3—breast cancer	0.000677	0.00102	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CALCA—breast cancer	0.000668	0.001	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—RPS6—breast cancer	0.00066	0.000992	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—FGF4—breast cancer	0.000655	0.000985	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CXCL12—breast cancer	0.000653	0.000981	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CXCR4—breast cancer	0.000653	0.000981	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PAK1—breast cancer	0.000641	0.000963	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—TCF7L2—breast cancer	0.00063	0.000946	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—AKT2—breast cancer	0.000627	0.000942	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—PIK3CG—breast cancer	0.000622	0.000935	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—HSP90AA1—breast cancer	0.000607	0.000912	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—NOTCH2—breast cancer	0.000607	0.000912	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—PIK3CD—breast cancer	0.000602	0.000905	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PRL—breast cancer	0.00059	0.000887	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—AGTR1—breast cancer	0.00059	0.000887	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—ADAM10—breast cancer	0.000582	0.000874	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—STK11—breast cancer	0.000582	0.000874	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PLG—breast cancer	0.000575	0.000865	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—AKT2—breast cancer	0.000569	0.000855	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—FGF10—breast cancer	0.000566	0.000851	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—PIK3CD—breast cancer	0.000547	0.000822	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PDGFA—breast cancer	0.000546	0.000821	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—TGFBR2—breast cancer	0.000538	0.000809	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—ITPR1—breast cancer	0.00053	0.000796	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—MMP3—breast cancer	0.000526	0.000791	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—STAT5A—breast cancer	0.000526	0.000791	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—ERBB4—breast cancer	0.000526	0.000791	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—PIK3CB—breast cancer	0.000525	0.000789	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—SMAD4—breast cancer	0.00051	0.000766	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—IGF1R—breast cancer	0.000507	0.000761	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—CXCL8—breast cancer	0.000504	0.000758	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—HES1—breast cancer	0.000498	0.000748	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PLA2G4A—breast cancer	0.000495	0.000743	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—NCOR1—breast cancer	0.000495	0.000743	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—FGF1—breast cancer	0.000489	0.000735	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CSF2—breast cancer	0.000489	0.000735	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—RAF1—breast cancer	0.000488	0.000733	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—NRG1—breast cancer	0.000486	0.00073	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—H2AFX—breast cancer	0.000482	0.000725	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—IL2—breast cancer	0.000482	0.000724	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—E2F1—breast cancer	0.000479	0.000719	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—PIK3CB—breast cancer	0.000477	0.000716	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—SPP1—breast cancer	0.00046	0.000691	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—CXCL8—breast cancer	0.000458	0.000688	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—ERBB3—breast cancer	0.000455	0.000684	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—FGFR2—breast cancer	0.000454	0.000683	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—IL2—breast cancer	0.000438	0.000658	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—TERT—breast cancer	0.000436	0.000655	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—FGFR1—breast cancer	0.000423	0.000636	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—HIF1A—breast cancer	0.000417	0.000627	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—LEP—breast cancer	0.000407	0.000612	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CAV1—breast cancer	0.000403	0.000606	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—KDR—breast cancer	0.000399	0.000599	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—ESR1—breast cancer	0.000389	0.000584	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—FN1—breast cancer	0.000384	0.000577	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—NFKBIA—breast cancer	0.000379	0.00057	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—NOTCH1—breast cancer	0.000376	0.000565	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—APC—breast cancer	0.000367	0.000552	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PIK3CG—breast cancer	0.000367	0.000552	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—KIT—breast cancer	0.000367	0.000552	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—EGF—breast cancer	0.000363	0.000546	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—MAPK3—breast cancer	0.000352	0.000529	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—BRAF—breast cancer	0.000345	0.000519	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—IGF1—breast cancer	0.000336	0.000505	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—AKT2—breast cancer	0.000336	0.000505	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—EGFR—breast cancer	0.000335	0.000503	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PIK3CD—breast cancer	0.000323	0.000485	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	0.00032	0.000481	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—SERPINE1—breast cancer	0.000319	0.00048	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—KRAS—breast cancer	0.000316	0.000475	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—NOS3—breast cancer	0.000305	0.000458	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	0.000291	0.000437	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—MDM2—breast cancer	0.000289	0.000435	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—RAF1—breast cancer	0.000288	0.000433	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—RELA—breast cancer	0.000287	0.000431	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—ERBB2—breast cancer	0.000285	0.000429	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—MTOR—breast cancer	0.000282	0.000423	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PIK3CB—breast cancer	0.000282	0.000423	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CXCL8—breast cancer	0.000271	0.000407	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—HRAS—breast cancer	0.000269	0.000404	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CDKN1B—breast cancer	0.000264	0.000397	CbGpPWpGaD
Levallorphan—OPRM1—GPCR downstream signaling—AKT1—breast cancer	0.000261	0.000393	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CASP3—breast cancer	0.000259	0.000389	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—IL2—breast cancer	0.000259	0.000388	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—IL6—breast cancer	0.000257	0.000387	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CCND1—breast cancer	0.000252	0.000379	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—JUN—breast cancer	0.000251	0.000378	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CTNNB1—breast cancer	0.00025	0.000375	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—MMP9—breast cancer	0.000245	0.000368	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—CDKN1A—breast cancer	0.000244	0.000366	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PTEN—breast cancer	0.000243	0.000366	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—MAPK8—breast cancer	0.000238	0.000358	CbGpPWpGaD
Levallorphan—OPRM1—Signaling by GPCR—AKT1—breast cancer	0.000237	0.000357	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—SRC—breast cancer	0.000226	0.000339	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—VEGFA—breast cancer	0.00022	0.00033	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—STAT3—breast cancer	0.000218	0.000327	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—MAPK3—breast cancer	0.000208	0.000312	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—MYC—breast cancer	0.000202	0.000304	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—TGFB1—breast cancer	0.000202	0.000303	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—EGFR—breast cancer	0.000198	0.000297	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—KRAS—breast cancer	0.000187	0.000281	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—PIK3CA—breast cancer	0.000172	0.000258	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—TP53—breast cancer	0.000166	0.000249	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—HRAS—breast cancer	0.000159	0.000239	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—IL6—breast cancer	0.000152	0.000228	CbGpPWpGaD
Levallorphan—OPRM1—Signaling Pathways—AKT1—breast cancer	0.00014	0.000211	CbGpPWpGaD
